Raleigh, NC, United States of America

Herbert H Seltzman

USPTO Granted Patents = 9 

 

Average Co-Inventor Count = 3.1

ph-index = 4

Forward Citations = 33(Granted Patents)


Company Filing History:


Years Active: 1986-2017

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Herbert H. Seltzman

Introduction

Herbert H. Seltzman is a notable inventor based in Raleigh, NC, with a significant portfolio of nine patents. His work primarily focuses on advancements in pharmacology, particularly in the field of cannabinoid research and its applications for chronic pain and other medical conditions.

Latest Patents

Seltzman's latest patents include groundbreaking developments such as "Peripherally-acting cannabinoid receptor agonists for chronic pain." This patent presents compounds, pharmaceutical compositions, and methods for utilizing these compounds effectively. Another significant patent is for the "Treatment of disorders associated with G protein-coupled receptor 35 (GPR35)." This innovation provides compounds that exhibit agonistic activity against GPR35, which are useful for antinociception, neuroprotection in cases of stroke or ischemia, and treating gastric inflammation.

Career Highlights

Throughout his career, Seltzman has made substantial contributions to the field of research. He has worked with reputable institutions such as the Research Triangle Institute and Temple University, where he has furthered his research and development efforts.

Collaborations

Some of his notable coworkers include Alan Bradley Fulp and Rangan Maitra, who have collaborated with him on various projects, enhancing the impact of his innovations.

Conclusion

Herbert H. Seltzman's contributions to the field of pharmacology and cannabinoid research highlight his innovative spirit and dedication to improving medical treatments. His patents reflect a commitment to addressing chronic pain and related disorders through scientific advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…